Fessler et al. have suggested that CD4+FOXP3+CD28− T cells might be a novel type of senescent Treg with reduced suppressive function, increased production of pro- and anti-inflammatory cytokines, and a positive correlation with clinical parameters of RA [36]. The gene discussed is CD28; the disease is rheumatoid arthritis.